Author:
Jones Esther L.,Laidlaw Stephen M.,Dustin Lynn B.
Abstract
TRIM21 (Ro52/SSA1) is an E3 ubiquitin ligase with key roles in immune host defence, signal transduction, and possibly cell cycle regulation. It is also an autoantibody target in Sjögren’s syndrome, systemic lupus erythematosus, and other rheumatic autoimmune diseases. Here, we summarise the structure and function of this enzyme, its roles in innate immunity, adaptive immunity and cellular homeostasis, the pathogenesis of autoimmunity against TRIM21, and the potential impacts of autoantibodies to this intracellular protein.
Funder
Kennedy Trust for Rheumatology Research
Subject
Immunology,Immunology and Allergy
Reference188 articles.
1. The Molecular Basis of Immune Regulation in Autoimmunity;Yang;Clin Sci (Lond),2018
2. The Immunobiology of Ro52 (TRIM21) in Autoimmunity: A Critical Review;Oke;J Autoimmun,2012
3. Anti-Ro/SSA Antibodies in Rheumatoid Arthritis: Clinical and Immunologic Associations;Cavazzana;Clin Exp Rheumatol,2006
4. Sjogren Syndrome;Brito-Zeron;Nat Rev Dis Primers,2016
5. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases;Fugger;Cell,2020
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献